Lada or Type 2 Diabetes Mellitus - A Challenging Diagnosis in Clinical Approach
, , , , and
Nov 03, 2021
About this article
Published Online: Nov 03, 2021
Page range: 55 - 58
Received: Aug 04, 2021
Accepted: Sep 02, 2021
DOI: https://doi.org/10.2478/amtsb-2021-0052
Keywords
© 2021 Lucia Mihaela Custură et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Latent autoimmune diabetes in adults (LADA) is a frequently encountered condition in medical practice. It should be suspected in patients where the type of the diabetes mellitus is not certain. LADA consists of features from both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), being a condition which is often unnoticed. Considered as type 1.5 diabetes mellitus, the lack of insulin requirement at disease onset makes it initially to be included in T2DM in terms of therapeutic management. The improvement of the screening methods allows the detection of LADA at an early stage, therefore medical intervention should be effective in preserving beta-cell function and to delay the progression of the disease.